Login

Beneath the Surface: A Coresaw Expedition | Mika Kähkönen - Managing Director of NTT CORESAW 00:10:00

Share On Facebook Share On Twitter

Mika Kähkönen is the Managing Director of NTT CORESAW

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
John K. Castle Discusses Castle Harlan | John K. Castle, Chairman and CEO, Castle Harlan.
00:10:00
Indicators Suggest an Imminent Recession: Colin Stewart of JC Clark Limited Analyzes Economic Risks and Debt Ceiling Negotiations
00:10:00
Journey of Success: Dr. Garo Armen's Inspiring Life and Impact on Science, Entrepreneurship, and Philanthropy |Hartley Atkinson, CEO, AFT Pharmaceuticals Ltd .
00:10:00
Designed to capture the full value of the worlds data|David Magerman,Managing Partner,Differential Ventures
00:10:00
Pioneering Affordable Quality: Our Mission to Revolutionize the Cannabis Industry with Consistent, High-Quality Products Across States|Leo Gontmakher, CEO , 4FRONT Ventures
00:10:00
Kazakhstan and Canada Strengthen Bilateral Ties on 20th Anniversary
00:10:00
Diversifying Your Portfolio: Beyond Traditional Options|Matt Burton,Partner,QED Investors
00:10:00
Andrew Ferguson on College Admissions and Higher Education Trends
00:10:00
Benoist Grossmann Discusses IDInvest's Venture Capital Strategy and Early Career Influences | Benoist Grossmann, Managing Partner, Idinvest Partners.
00:10:00
Revolutionizing Aerial Application with AgNav's Precision GPS Guidance Systems.
00:10:00
The Role of Technology in Modern Family Offices: Insights from Greg Harris | Greg Harris - Partner and Head of Family Office – British Islands, Stonehage
00:00:00
Soligenix CEO Chris Schaber highlights the company's major milestones - Christopher J. Schaber, PhD Chairman, President and Chief Executive Officer, Soligenix Inc

© 2026 Nehu